Prostate Cancer Diagnosis and Treatment Enhancement through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer. PIONEER brings together 34 private and public stakeholders from 9 countries in one multidisciplinary research consortium with the aim of positively transforming the field of prostate cancer clinical care by answering pressing questions related to prostate cancer screening, diagnosis and treatment. PIONEER has developed a unique state-of-the-art big data analytic platform by integrating existing data sources from patients with prostate cancer. PIONEER leveraged this platform to address prioritized research questions, filling knowledge gaps in the characterization, management and core outcomes of prostate cancer across the different disease stages. The network has benefited from sustained patient and stakeholder involvement and engagement, but many challenges remain when using real-world data for big data projects. To continue to advance prostate cancer care, data need to be available, suitable methodologies should be selected and mechanisms for knowledge sharing must be in place. Now acting as the prostate cancer arm of the European Association of Urology's new endeavour, UroEvidenceHub, PIONEER maintains its goal of maximizing the potential of big data to improve prostate cancer care.
Nature reviews. Urology. 2024 Sep 09 [Epub ahead of print]
Ailbhe Lawlor, Katharina Beyer, Beth Russell, Carl Steinbeisser, Anders Bjartell, Bertrand De Meulder, Muhammad Imran Omar, Tim Hulsen, John Butler, James N'Dow, Juan Gómez Rivas, Giorgio Gandaglia, Rossella Nicoletti, Vasileios Sakalis, Emma Jane Smith, Monika Maass, Jihong Zong, Louise Fullwood, Thomas Abbott, Azadeh Tafreshiha, Kishore Papineni, Robert Snijder, Denis Horgan, Sarah Seager, Susan Evans-Axelsson, Maria J Ribal, Monique J Roobol, Mieke Van Hemelrijck, PIONEER Consortium
Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK. ., Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., Transforming cancer OUtcomes through Research (TOUR), King's College London, London, UK., Collaborate Project Management, Munich, Germany., Department of Translational Medicine, Lund University, Malmö, Sweden., European Institute for Systems Biology & Medicine, Lyon, France., Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland., Data Science & AI Engineering, Philips, Eindhoven, the Netherlands., Bayer AB, Medical Affairs Oncology, Stockholm, Sweden., European Association of Urology, Guidelines Office, Arnhem, the Netherlands., Department of Urology, Clínico San Carlos University Hospital, Madrid, Spain., Università Vita-Salute San Raffaele, Milan, Italy., Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy., Department of Urology, Hippokrateion General Hospital of Thessaloniki, Thessaloniki, Greece., ARTTIC Innovation GmbH, Munich, Germany., Bayer Healthcare, Global Medical Affairs Oncology, Whippany, NJ, USA., Pinsent Masons, Leeds, UK., Astellas Pharma, Inc, Northbrook, IL, USA., The Hyve, Utrecht, The Netherlands., European Alliance for Personalized Medicine, Brussels, Belgium., Analytics & AI, IQVIA, Reading, UK.